Cargando…
Insulin Resistance and Cancer: In Search for a Causal Link
Insulin resistance (IR) is a condition which refers to individuals whose cells and tissues become insensitive to the peptide hormone, insulin. Over the recent years, a wealth of data has made it clear that a synergistic relationship exists between IR, type 2 diabetes mellitus, and cancer. Although t...
Autores principales: | Chiefari, Eusebio, Mirabelli, Maria, La Vignera, Sandro, Tanyolaç, Sinan, Foti, Daniela Patrizia, Aversa, Antonio, Brunetti, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540232/ https://www.ncbi.nlm.nih.gov/pubmed/34681797 http://dx.doi.org/10.3390/ijms222011137 |
Ejemplares similares
-
Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes
por: Mirabelli, Maria, et al.
Publicado: (2019) -
Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases
por: Mirabelli, Maria, et al.
Publicado: (2020) -
Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
por: Mirabelli, Maria, et al.
Publicado: (2021) -
Comment on: Marquez et al. Low-Frequency Variants in HMGA1 Are Not Associated With Type 2 Diabetes Risk. Diabetes 2012;61:524–530
por: Brunetti, Antonio, et al.
Publicado: (2012) -
Potential Benefits and Harms of Novel Antidiabetic Drugs during COVID-19 Crisis
por: Mirabelli, Maria, et al.
Publicado: (2020)